Abstract:Objective: This study aimed to investigate the roles of neurotrophic factors (NTFs), monoamine neurotransmitters, and inflammatory processes in the pathophysiology of the comorbidity of epilepsy and depression. Methods: A retrospective analysis was conducted with 57 epilepsy patients (PWE), 50 patients with epilepsy and comorbid depression (PWECD), and 47 healthy controls (HC) admitted between June 2020 and June 2024. Serum levels of brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), 5-hydroxytryptamine (5-HT), norepinephrine (NE), dopamine (DA), interleukin-1β (IL-1β), and interleukin-6 (IL-6) were measured using enzyme-linked immunosorbent assay (ELISA). Additionally, BDNF and GDNF levels in cerebrospinal fluid (CSF) samples were analyzed from selected patients in the PWE and PWECD groups. Results: Serum BDNF levels were significantly lower in both PWE and PWECD groups compared to HC, while no differences between the former two groups. GDNF levels were lower in PWECD compared to HC, but not between PWE and HC. Serum 5-HT was significantly reduced in PWECD compared to both HC and PWE groups. No significant differences were observed in serum DA, NE, and IL-6 levels across the groups. Serum IL-1β levels were elevated in the PWECD group compared to the HC group. The Self-Rating Depression Scale (SDS) score negatively correlated with serum 5-HT and GDNF levels. In terms of predictive ability, serum BDNF demonstrated higher accuracy for the diagnosis of epilepsy [area under the curve, AUC = 0.701, 95% confidence intervals (95% CI) 0.601 ~ 0.801], while serum 5-HT was the best marker for predicting the development of depression in epilepsy patients (AUC = 0.727, 95% CI 0.632 ~ 0.821). No significant correlation was found between serum and CSF BDNF levels within the same subject ( r = 0.155; p = 0.221; Spearman correlation), and CSF GDNF levels were too low to be clinically informative. Conclusion: The findings suggest the involvement of NTFs, monoamine neurotransmitters, and inflammatory processes in the pathogenesis of epilepsy and depression. Decreased serum BDNF levels correlate with epilepsy but not necessarily with comorbid depression, while serum GDNF and 5-HT show potential clinical value in diagnosing this comorbidity. However, the deficient levels of NTFs in CSF suggest a need for more sensitive detection methods.

Relation Mechanism of Epilepsy and Depressive Disorder (review)

Extracellular Vesicles in Mental Disorders: A State-of-art Review.

Exploring the association between epilepsy and depression: A systematic review and meta-analysis

The Role of Vesicle Release and Synaptic Transmission in Depression

A Review of Research on the Association between Neuron-Astrocyte Signaling Processes and Depressive Symptoms

The roles of extracellular vesicles in major depressive disorder

The neurobiology of depression: An integrated view

Brain structural and functional changes in patients with major depressive disorder: a literature review

Functional Network Changes in the Hippocampus Contribute to Depressive Symptoms in Epilepsy.

Exploring the Association between BDNF related Signaling Pathways and Depression: A Literature Review

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Research on Pathological Mechanism of Depression and Antidepressant Drug Target

Progress of Receptors, Cytokine and Signal Pathways about Depression

Neurobiochemical and Neuroelectrophysiologic Studies of Depression

Common Pathomechanism of Migraine and Depression.

Microglia as a Game Changer in Epilepsy Comorbid Depression

Research Progress on Neural Circuit Mechanisms of Depression

Epilepsy and demyelination: towards a bidirectional relationship

Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression

The Role of Epigenetic Regulation in Etiology of Major Depressive Disorder

Molecular Biological Aspects of Depressive Disorders: A Modern View